                                                                                                               Vol 444 | 16 November 2006 | doi:10.1038/nature05284




LETTERS
A protein interaction network for pluripotency of
embryonic stem cells
Jianlong Wang1, Sridhar Rao1, Jianlin Chu1, Xiaohua Shen1, Dana N. Levasseur1, Thorold W. Theunissen1
& Stuart H. Orkin1,2


Embryonic stem (ES) cells are pluripotent1,2 and of therapeutic                          identified by whole-lane liquid chromatography–tandem mass spec-
potential in regenerative medicine3,4. Understanding pluripotency                        trometry (LC–MS/MS) are summarized in Fig. 1d (left panel; see also
at the molecular level should illuminate fundamental properties of                       Supplementary Data). With criteria described in the Supplementary
stem cells and the process of cellular reprogramming. Through cell                       Methods, putative Nanog-associated proteins were chosen (Fig. 1d,
fusion the embryonic cell phenotype can be imposed on somatic                            right panel). The candidates, which are predominantly transcription
cells, a process promoted by the homeodomain protein Nanog5,                             factors or components of transcriptional complexes, include proteins
which is central to the maintenance of ES cell pluripotency6,7.                          previously studied in an ES cell context (for example Oct4 or Dax1)
Nanog is thought to function in concert with other factors such                          and fall into three groups. The first group includes proteins present in
as Oct4 (ref. 8) and Sox2 (ref. 9) to establish ES cell identity. Here                   at least two of three independent one-step purifications and tandem
we explore the protein network in which Nanog operates in mouse                          purification. These proteins (Sall1, Sall4, Rif1, Tif1b, Mybbp, Dax1
ES cells. Using affinity purification of Nanog under native condi-                       and Nac1) are prime interaction candidates. The second group
tions followed by mass spectrometry, we have identified physically                       includes proteins (Zfp281, Err2, Elys, Oct4, Zfp198, NF45 and
associated proteins. In an iterative fashion we also identified                          HDAC2) that may be part of unstable or transient complexes that
partners of several Nanog-associated proteins (including Oct4),                          dissociate during tandem purification. Proteins in the third group
validated the functional relevance of selected newly identified                          (REST, Sp1 and Wapl) seem ‘masked’ in one-step purifications
components and constructed a protein interaction network. The                            but are recovered in the tandem procedure. Proteins identified by
network is highly enriched for nuclear factors that are individually                     our approach may interact directly with Nanog, or more often indir-
critical for maintenance of the ES cell state and co-regulated on                        ectly through their association with other components of a protein
differentiation. The network is linked to multiple co-repressor                          complex.
pathways and is composed of numerous proteins whose encoding                                 We then validated selected Nanog-interacting candidates by per-
genes are putative direct transcriptional targets of its members.                        forming co-immunoprecipitation experiments. Interactions between
This tight protein network seems to function as a cellular module                        Nanog and Dax1, Nac1, Zfp281 and Oct4 were confirmed in hetero-
dedicated to pluripotency.                                                               logous 293T (Supplementary Fig. S2) and ES (Fig. 2a–d) cells tran-
   To recover Nanog with its associated proteins, we used a biotiny-                     siently transfected with constructs as indicated (see the figure legend
lation/proteomics approach10. Nanog complementary DNA bearing                            for details). In addition, we generated ES cells expressing biotinylated
an amino-terminal Flag epitope and a short peptide tag that serves as                    Nac1, Zfp281, Dax1 and Oct4, at or below endogenous protein levels
a substrate for in vivo biotinylation (Fig. 1a) was expressed at about                   (Supplementary Fig. S3), for affinity capture with anti-streptavidin-
20% of the endogenous level in ES cells previously engineered to                         agarose and western blotting with anti-streptavidin–horseradish per-
express Escherichia coli biotin ligase BirA (Fig. 1b, left). Low-level                   oxidase (HRP) antibody. We confirmed that Nanog co-purifies with
                                                                                         bio
expression reduces the likelihood that non-physiological interactions                       Nac1, bioZfp281, bioDax1 and bioOct4 (Fig. 2e) and that Nac1 co-
will be identified or that the stoichiometry of protein complexes will                   purifies with bioNanog (Fig. 2f). Furthermore, we confirmed the
be perturbed11. Biotinylated Nanog (bioNanog) is efficiently recov-                      association of Rif1 with endogenous Nanog (Fig. 2g), as well as ecto-
ered from ES cell nuclear extracts with streptavidin (SA)-agarose                        pically expressed Nanog (Fig. 2h, i).
(Fig. 1b right), and is biologically active, because its expression                          To test the functional relevance of selected components, we
attenuates the dependence of ES cells on leukaemia inhibitory factor                     employed inhibition of endogenous RNAs by short hairpin RNA
(LIF; Supplementary Fig. S1). Cells coexpressing BirA and bioNanog                       (shRNA; Supplementary Fig. S4). If Nanog-associated proteins influ-
are functionally equivalent to wild-type ES cells in stem-cell marker                    ence Nanog’s transcriptional activity, their loss of function would be
gene expression (Supplementary Fig. S1). On size fractionation of ES                     expected to affect ES cell pluripotency. We first examined shRNAs
cell nuclear extracts, bioNanog and endogenous Nanog behave simi-                        directed to Dax1 and Sall4 in ES cells that express green fluorescent
larly, broadly distributed with an apparent molecular mass of more                       protein (GFP) under the control of Oct4 regulatory elements. In both
than 160 kDa to 1 MDa, far greater than that of the predicted poly-                      instances a loss of pluripotency was observed, as revealed by dimin-
peptide (34 kDa) (Fig. 1c).                                                              ished Oct4 expression and concomitant derepression of selected lin-
   To identify Nanog-associated proteins we used single-step capture                     eage-specific markers (Supplementary Fig. S5). Recent conditional
on streptavidin beads10, as well as tandem purification with anti-Flag                   gene targeting of Dax1 (ref. 12) and Sall4 (ref. 13) provides inde-
immunoprecipitation followed by capture with streptavidin. Nuclear                       pendent support for their crucial function in ES cells.
extracts of ES cells expressing either BirA alone or BirA plus bioNanog                      Further functional validation included shRNA inhibition of
were processed in parallel. Total peptides sequenced and proteins                        two Nanog-associated proteins, Nac1 and Zfp281, not previously
1
  Division of Hematology–Oncology, Children’s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Harvard Stem Cell Institute, 2Howard Hughes Medical Institute,
Boston, Massachusetts 02115, USA.
364
                                                                    ©2006 Nature Publishing Group
NATURE | Vol 444 | 16 November 2006                                                                                                                                                                                                                                               LETTERS


examined in ES cells. Nac1 is a BTB-domain containing protein14,15                                                                                                           and S6). To assess the relevance of Nac1 and Zfp281 with respect to
related to Drosophila bric-a-brac/tramtrack, which prevents inappro-                                                                                                         transcriptional control, we examined chromatin occupancy of these
priate neural gene expression. Zfp281, the mouse homologue of                                                                                                                proteins at the Gata6 promoter in wild-type ES cells. As shown in
human zinc-finger protein ZBP99, may regulate cell proliferation,                                                                                                            Fig. 3d, Nac1 and Zfp281, as well as Nanog, are highly enriched at the
differentiation and oncogenesis16. We infected wild-type ES cells with                                                                                                       Gata6 promoter. These data strongly implicate Nac1 and Zpf281,
retrovirus containing an shRNA vector carrying a GFP cassette                                                                                                                along with Nanog, in the tight control of this crucial target gene
(Supplementary Fig. S4) and isolated GFPhigh clones harbouring                                                                                                               and also show that derepression of Gata6 expression in knockdown
Nac1 and Zfp281 shRNAs. Two clones each with similar extents of                                                                                                              cells is not due to off-target effects of shRNAs.
RNA knockdown (about 80% for Nac1 and about 70% for Zfp281;                                                                                                                      The broad pattern of Nanog on size fractionation, and the iden-
Fig. 3a) were studied in detail. Nac1 or Zfp281 knockdown cells                                                                                                              tification and validation, both physically and functionally, of asso-
maintained on a feeder layer formed small colonies, yet they retained                                                                                                        ciated proteins suggest that Nanog is a component of multiple
proper ES cell morphology (Fig. 3b, top panels). On passage to gela-                                                                                                         protein complexes. By performing similar proteomic analyses on
tin in the presence of LIF, knockdown cells grew poorly and formed                                                                                                           several of the Nanog-associated proteins, as well as another stem-
disorganized clumps of small cells (Fig. 3b, bottom panels). Striking                                                                                                        cell marker protein Rex1 (ref. 17), we sought to identify additional
derepression of primitive endoderm (Gata6/4), mesoderm/visceral                                                                                                              previously unknown proteins and components shared between
endoderm (Bmp2) and neuroectoderm (Isl1) markers was observed,                                                                                                               complexes and to develop a protein network (Fig. 4a). The size
despite normal expression of the stem-cell markers (Nanog, Oct4                                                                                                              distributions of complexes containing Oct4, Dax1, Nac1, Zfp281
and Rex1; Fig. 3c). Validation of these findings was achieved through                                                                                                        and Rex1 overlap that of Nanog (Supplementary Fig. S7). We
the use of an independent shRNA directed to Zfp281 and by exam-                                                                                                              employed ES cell lines expressing bioDax1, bioNac1, bioZfp281,
ination of gene-targeted Nac11/2 ES cells (Supplementary Figs S4                                                                                                             bio
                                                                                                                                                                                 Oct4 and bioRex1 (Fig. 2e, and Supplementary Fig. S3) for the


                                                                                                                                                  NE IP anti-SA-
a                                                                                                           b            Total lysates                agarose
                                                                                                                                                                                                      5                                                     V5
                                                                                                                                                                                                 V5 V
                              MSGLNDIFEAQKIEWHEGAPSSR
                                                                                                                  BirA –        +    +            BirA + +                                                                5 V5                       V 5 81                       5
                                                                                                                                                                                                                                                                                AV ct4V
                                                                                                                                                                                                                                                                                        5
                                                                                                                                                                             a                 rA ax1         b        A V c1  c                 i rA fp2      d
                                                                                                                                                                                                                                                                          Bir
                                                                                                                                                                                                                   Bi r Na
                                                                                                            bioNanog   –        –    +                                                       i
                                                Bio
                                                                                                                                             bioNanog –    +                                B D                                                B      Z                           O    WB
     BirA                                                  bioNanog
                                           +                                                                                               endbioP
                                                                                                                                                                             IP anti-V5

                                               FL                                                                                                                                                                                                                                   Anti-Nanog
Co-express in J1 ES Cells
                    cells                                                                                                                 bioNanog
                                                                                                                                                                                                                                                                                    Anti-V5
Purify biotinylated protein                                                                                              Anti-SA–HRP bio                                                                                                                                            <BirA
         using SA                                                                                                                       Nanog
                                                                                                                                                                 bioNanog
                                                                                                                                          endNanog
                                                                                                                           1 2 3                         1 2                                                                                                                        Anti-Nanog
                                                                                                                          Anti-Nanog                 Anti-SA–HRP
                                                                                                                                                                             Input




c                                                   Void                                                                700 kDa 440 kDa 232 kDa          158 kDa                                       *                                                                            Anti-V5
     Anti-                                                                                                                                                       bioNanog                                                                                                           <BirA
    Nanog                                                                                                                                                      = end
                                                                                                                                                                     Nanog
 Anti-SA                                                                                                                                                       - bioNanog    e               BirA BirA            BirA     BirA           BirA           f          BirA + +
                                                                                                                                                                                                                                                           bioNanog      – +
                                                                                                                                                                                              – bioNac1       bioZfp281 bioDax1 bioOct4
                                                                                                                                                                                                                                                                                     WB




                                                                                                                                                                                                                                                                 (bioNanog)
d                                                                                                           Protein ID           Peptide nos          Peptide nos
                                                                                                                                                                                    IP SA




                                                                                                                                                                                                                                                                                    Anti-Nac1




                                                                                                                                                                                                                                                                     IP SA
                                                                                                                               (MS1+MS2+MS3)           (Tandem)
                                           10 168 98                                                                                                                                                                                             Nanog
                                                                                                                Nanog                4+7+8                4
                                                                                                                                                                                                           WB anti-Nanog                                                            Nac1
                                                                                                                Sall1                3+2+1                1
                                            One-step
                                                                                                                                                                                    Input




                                             (MS1)                                                              Sall4                4+2+14               8
     Total 2,530 peptides (178 proteins)




                                                                      Total 3,410 peptides (266 proteins)




                                                                                                                                                                                                                                                                      Input
                                                                                                                                                                                                                                                 Nanog                              Anti-SA
                                                                                                                 Rif1                12+5+5               3
                                                                                                                                                                                                           WB anti-Nanog
                                                                                                                Tif1β               11+16+13              15                                                                                                                        bioNanog
                                                                                                                                                                                                                g




                                           20 132 66
                                                                                                                                                                                                             no




                                                                                                                Mybbp               8+14+15               2                  g                                                                               i
                                                                                                                                                                                                                                                       5



                                                                                                                                                                                                                                h
                                                                                                                                                                                                    An rum
                                                                                                                                                                                                    An if1




                                                                                                                                                                                                                                                 gV




                                                                                                                                                                                                                                                                    BirA + +
                                                                                                                                                                                                          Na




                                                                                                                                                                                                                                            Na 5
                                                                                                                                                                                                          R




                                                                                                                                                                                                                                                V
                                                                                                                                                                                                                                              no




                                                                                                                Dax1                 0+1+2                1
                                                                                                                                                                                                      se




                                                                                                                                                                                               IP
                                                                                                                                                                                                      ti-
                                                                                                                                                                                                      ti-




                                                                                                                                                                                                                                                             bioNanog
                                                                                                                                                                                                                                             rA




                                            One-step                                                                                                                                                                                                                     – +          WB
                                                                                                                                                                                                                                          Bi
                                                                                                                                                                                                                              anti-V5
                                                                                                                                                                                                  PI




                                                                                                                Nac1                 2+0+2                2                           WB                                                                                               Rif1
                                                                                                                                                                                                                                                                  (bioNanog)


                                             (MS2)
                                                                                                                                                                                                                                IP




                                                                                                                                                                                                                                                                      IP SA




                                                                                                                Zfp281               1+2+4                0                           Anti-                         Rif1                         Rif1
                                                                                                                 Err2                7+2+1                0                            Rif1                                          WB anti-Rif1                                    Anti-Rif1
                                                                                                                                                                                                                   bioNanog/lgG
                                           10 107 88                                                             Elys                1+2+1                0                           Anti-
                                                                                                                                                                                                       *
                                                                                                                                                                                                                                  Input




                                                                                                                Oct4                 2+0+1                0
                                                                                                                                                                                     Nanog                         endNanog
                                                                                                                                                                                                                                                                       Input




                                                                                                                                                                                          Anti-                                                  Rif1                                Anti-SA
                                            One-step                                                            Zfp198               0+2+5                0                                                         Rif1
                                                                                                                                                                                                                                     WB anti-Rif1
                                                                                                                                                                               Input




                                             (MS3)                                                              NF45                 4+0+1                0                                Rif1
                                                                                                             HDAC2                   2+1+0                0                               Anti-                    bioNanog                                                          bioNanog
                                                                                                                                                                                            SA
                                                                                                                REST                 0+0+1                12
                                           1 10 30
                                                                                                                 Sp1                 0+1+0                1                  Figure 2 | Confirmation of Nanog association by co-immunoprecipitation
                                            Tandem                                                              Wapl                 0+0+1                1                  in ES cells. a–d, Co-immunoprecipitation of Nanog and Dax1 (a), Nac1
                                                                                                                                                                             (b), Zfp281 (c) and Oct4 (d) in ES cells expressing BirA without (a, b) or with
Figure 1 | Protein complexes containing Nanog protein in mouse ES cells.                                                                                                     (c, d) bioNanog. The asterisk marks a faint band in a. IP,
a, Strategy for biotinylation of Nanog in ES cells. Flag (FL) and 23-amino-                                                                                                  immunoprecipitation. e, f, Co-immunoprecipitation of Nanog and Nac1,
acid biotin (Bio) tags are indicated. SA, streptavidin. b, Western blot                                                                                                      Zfp281, Dax1 and Oct4 in ES cells expressing bioNac1, bioZfp281, bioDax1,
analyses of expression of biotinylated Nanog (bioNanog) as well as                                                                                                           bio
                                                                                                                                                                                Oct4 (e) and bioNanog (f). g–i, Co-immunoprecipitation of Nanog and
endogenous Nanog (endNanog) (left), and binding of bioNanog to SA beads                                                                                                      Rif1 in ES cells. In g, nuclear extracts from ES cells expressing BirA and
                                                                                                                                                                             bio
(right). IP, immunoprecipitation. c, Western blots of fractions using anti-                                                                                                     Nanog were incubated with preimmune (PI) serum, anti-Rif1 antibody,
Nanog (top) and anti-SA–HRP antibodies (bottom). d, Summary of LC–MS/                                                                                                        and anti-Nanog antibody, respectively, followed by capture with protein-A/
MS results from three independent one-step purifications and a tandem                                                                                                        G agarose. The asterisk indicates endogenous Nanog immunoprecipitated
purification. Total peptides sequenced and proteins identified in BirA (black                                                                                                by anti-Rif1 antibody. Note that bioNanog migrates together with the IgG
circles) and bioNanog (red circles) samples are indicated. Components of                                                                                                     band. Antibodies for IP and western blot (WB) analyses are indicated. In
Nanog complexes selected with the criteria described in Supplementary                                                                                                        h and i, experiments similar to those in a and f were performed except that
Methods are listed in the table.                                                                                                                                             different constructs and antibodies were used.
                                                                                                                                                                                                                                                                                            365
                                                                                                                                                       ©2006 Nature Publishing Group
LETTERS                                                                                                                                                                                                        NATURE | Vol 444 | 16 November 2006



                                                                                                                         Mock                                        Nac1.2872 shRNA                 Zfp281.1691 shRNA
                            a                                                                      b
                                                                        Zfp281




                           shRNA/mock




                                                                        0.34
                                              Nac1




                                                                                      0.31
                                                           0.19
                                             0.16
                                             1             2            1             2
                                o       ne          on
                                                       e
                                                               o   ne          on
                                                                                  e
                             Cl               Cl            Cl          Cl

                            c                                                                                                                      d




                                                                                                                                                                                                               101.6
                                                                                                                                            15.0
                                                                        11.9
                                                                                 9.0




                                                                                                                   8.8
                                                                                                             6.6




                                                                                                                                                                                            69.6
                                                                                                                                4.2




                                                                                                                                                    Biotin-tagged/BirA
                                                                                                       2.5
                                                                                             1.7
                                                     1.9
                                         1.8


                                                               1.8




                                                                                                                                      1.0
                                                                                                                          0.9
                           shRNA/mock




                                                                        46.6
                                                                                  25.9




                                                                                                                                                                         21.9
                                                                                                                                             9.9
                                                                                                                   8.6
                                                                                                       4.0
                                                                                             2.4


                                                                                                             0.8
                                                               2.1




                                                                                                                                      0.9
                                                                                                                          1.6
                                         1.7




                                                                                                                                0.9
                                                     1.1




                                                                                                                                                                                                   1.6
                                                                                                                                                                                                         2.2




                                                                                                                                                                                                                             1.3
                                                                                                                                                                                                                       1.1
                                                                                                                                                                                0.8
                                                                                                                                                                                      1.0
                                   og

                                                    4
                                                  x1

                                             G 6
                                            H a4
                                            La 4a
                                           ac b1

                                             Bm y
                                             Bm 2
                                             C 4
                                                    2
                                                  f5
                                                   l1
                                                 ur
                                                ct


                                                  a




                                                 p
                                                 p
                                                dx


                                                Is
                                              Fg
                                              Re

                                               at
                                               at

                                                F
                           an




                                         Br m
                                             hy
                                              O




                                             N
                                             G
                          N




                                                                                                                                                                          bioNac1           bioNanog           bioZfp281


Figure 3 | Functional validation by RNA-mediated interference.                                                                                     RT–PCR analysis of stem-cell markers as well as lineage-specific markers as
a, Quantitative reverse transcriptase–polymerase chain reaction (RT–PCR)                                                                           indicated in Nac1.2872 knockdown cells (top) and Zfp281.1691 knockdown
analysis of Nac1 and Zfp281 gene expression (two clones each) after shRNA-                                                                         cells (bottom). d, Quantitative real-time chromatin immunoprecipitation of
mediated knockdown in wild-type ES cells. b, Morphology of ES cells                                                                                biotin-tagged proteins on Gata6 (black bars) as well as Gapdh (grey bars) and
infected with virus containing empty shRNA vector (Mock; left), Nac1                                                                               b2 microglobulin (white bars) promoter sequences (as negative controls).
shRNA (middle) or Zfp281 shRNA (right). ES cells were grown either on                                                                              Results are shown as means and s.e.m. from two clones in c and three
feeders (top) or on gelatin in the presence of LIF (bottom). c, Quantitative                                                                       independent experiments in d.


affinity purification of complexes, as described for bioNanog.                                                                                     for the network proteins relative to Rex1. For comparison, a ‘control’
Proteins were identified with the criteria applied for the selection                                                                               set of randomly chosen gene transcripts was similarly analysed
of Nanog-associated proteins and are summarized in Fig. 4a.                                                                                        (Supplementary Fig. S8). We chose Rex1 as a comparator because
Multiple proteins are shared between the different complexes. A                                                                                    it is abruptly and extensively downregulated on the differentiation of
protein interaction map (or mini-interactome)18 summarizes these                                                                                   ES cells. Co-regulation of genes in the network is consistent with their
observations (Fig. 4b). Several features suggest that the network is                                                                               participation in a common cellular function or pathway.
specialized to establish and/or maintain ES cell pluripotency.                                                                                         Third, in reinforcement of this hypothesis, we find that many (at
   First, the network is remarkably enriched for proteins that have                                                                                least 56%) of the genes encoding proteins of the mini-interactome
been shown, or are likely, to be required individually for controlling                                                                             have been reported as putative Nanog and/or Oct4 targets in
the survival or differentiation of the inner cell mass, or aspects of early                                                                        recent ChIP-on-chip20 or ChIP-PET19 analyses of chromatin
development. These include 15 proteins (Fig. 4b, green circles) with                                                                               occupancy in human or mouse ES cells (Supplementary Table S2).
known phenotypic alleles in published knockout studies or commu-                                                                                   Thus, ‘downstream’ gene targets of Nanog and Oct4 also serve as
nicated to us (Supplementary Table S1), and 4 proteins (blue circles)                                                                              ‘upstream’ effectors in the pluripotency network. Although this fea-
from shRNA-mediated inhibition described previously19 or in this                                                                                   ture may stabilize aspects of the ES cell state, it also renders the
study (Fig. 3, and Supplementary Figs S5 and S6). Three other pro-                                                                                 network vulnerable to attack at multiple points rather than at very
teins (yellow circles) have known phenotypes that are not consistent                                                                               few21.
with an early requirement in development (Supplementary Table                                                                                          Fourth, the network is linked to several cofactor pathways, which
S1). Thus, more than 80% of proteins for which knockout or knock-                                                                                  are largely involved in mediating transcriptional repression. These
down studies have been performed seem essential for early devel-                                                                                   include the histone deacetylase NuRD (P66b and HDAC2), poly-
opment and/or ES cell properties. To approximate the ‘expected’                                                                                    comb group (YY1, Rnf2 and Rybp) and SWI/SNF chromatin remod-
fraction of essential genes, we curated 300 random transcription                                                                                   elling (BAF155) complexes. Of potential interest, Rex1 and Oct4, as
factor genes and found that less than 15% of those expressed in ES                                                                                 contrasted with Nanog or its closest partners (for example Dax1,
cells had knockout phenotypes consistent with an early requirement                                                                                 Sall4 and Nac1), are associated with polycomb components. Nanog
(data not shown).                                                                                                                                  is linked to HDAC/NuRD through its association with Sall1/4 (ref.
   Second, most genes encoding the proteins within the network are                                                                                 22) and Nac1 (ref. 23). The involvement of multiple co-repressor
co-regulated, and specifically downregulated, on ES cell differenti-                                                                               complexes provides both a method of regulating different sets of
ation. In Fig. 4c, a rank order depicts the expression of transcripts                                                                              target genes and a fail-safe mechanism to prevent differentiation
366
                                                                                                                   ©2006 Nature Publishing Group
NATURE | Vol 444 | 16 November 2006                                                                                                                                                               LETTERS




                                                         a      Nanog                                                                                          Rex-1




                                                                                         Dax1             Nac1             Zfp281             Oct4


                                                                 Nanog              Dax1                  Nac1           Zfp281            Oct4                 Rex1
                                                               complexes          complexes             complexes      complexes         complexes            complexes
                                                                    Nanog                                                                                       Rex1
                                                                    Oct4                                  Oct4                                 Oct4             Oct4
                                                                    Sall1                                 Sall1                               RYBP              YY1
                                                                    Nac1                                  Nac1              EWS                EWS              Nac1
                                                                    Zfp281            Zfp609             Zfp281            Zfp281             Zfp219            Etl1
                                                                    Zfp198                                Ari3a                                                 Rai14
                                                                     Elys                                Arid3b                               Arid3b            Prmt1
                                                                    NF45                                Btbd14a                               NF45              Rnf2
                                                                    Wapl                                                                                        Wapl
                                                                HDAC2                  PELO                                                   HDAC2
                                                                    REST               REST               P66β                                 P66β
                                                                     Sp1                 Sp1             Wdr18                                 Sp1             Wdr18
                                                                    Dax1               Dax1              BAF155             Cdk1              Cdk1             BAF155
                                                                     Err2                Err2                             Requiem            Requiem          Requiem
                                                                    Sall4                Sall4            Sall4             Sall4              Sall4
                                                                    Tif1β              Tif1β                                                                    Tif1β
                                                                     Rif1              (Rif1)             (Rif1)            (Rif1)
                                                                    Mybbp                                (Mybbp)


                    b                                                                                  Rybp                                               c
                                                                                                                 Zfp219                                                   Time (days)
                                                                    Requiem
                                                                                                                                                               0.25

                                                                                                                                                               0.75
                                                                                                                                                               0.5


                                                                                                                                                               1.5
                                                                                                                            Cdk1




                                                                                                                                                               14
                                                                                                                                                               0



                                                                                                                                                               1

                                                                                                                                                               2
                                                                                                                                                               4
                                                                                                                                                               7
                                                                                                                                                               9
                                Rai14     YY1     Rnf2
                                                                     Arid3b                                                                                                             Rex1
                        Prmt1                                                                                                        EWS
                                                                                                                                                                                        Dax1
                                                             P66β
                                                                                                                                                                                        Mybbp
                                                                                                                                                                                        Etl1
                                                                                                       Oct4                                    NF45                                     Err2
                    Etl1                                                                                                                                                                Oct4
                                                                                                                                                                                        Tif1β
                                                                                                                                                   HDAC2
                                                                                                                                                                                        Elys
                                        Rex1                            Wapl                                                                                                            Prmt1
                                                                                            Sall4
                                                                                                                                                                                        Wdr18
                                                                                                                          Zfp281
                                                                                                                                                                                        REST
                                         Wdr18                                                                                                                                          Rif1
                        BAF155
                                                                                                                                                                                        BAF155
                                                                                                                                                                                        Zfp281
                                                                                                                                             Sp1                                        EWS
                                                                                                                                                   Elys                                 Rai14
                                                                                                                                                                                        Sall1
                                                                                                                      Nanog                                                             Sall4
                                                              Nac1                                                                                   Zfp198                             Nanog
                                         Arid3a                                                 Rif1                                                                                    Nac1
                                                                                 Tif1β
                                                                                                                                                   Err2
                                                                                                                                                                                        NF45
                                                    Btbd14a                                                                                                                             HDAC2
                                                                                                                                                                                        Wapl
                                                                              Sall1                                                                                                     Sp1
                                                                                                Mybbp                                          REST                                     Zfp219
                                                                                                                       Dax1
                                                                                                                                                                                        Btbd14a
                                                                                                                                                                                        Cdk1
                                                                                                               Pelo                 Zfp609                                              Zfp609
                                                                                                                                                                                        P66β
                                                                                                                                                                                        Requiem
                                                                                                                                                                                        YY1
                                                                                                                                                                                        Rnf2
                                                                                                                                                                                        Pelo
                                                                                                                                                                                        Zfp198
                                                                                                                                                                                        Rybp
                                                                                                                                                                                        Arid3b
                                                                                                                                                                                        Arid3a

Figure 4 | A protein interaction network in ES cells. a, Schematic depiction                                          tagged baits for affinity purification. Green lines indicate interactions
of the strategy for mapping protein–protein interaction network in ES cells.                                          confirmed by co-immunoprecipitation and the red line indicates interaction
Starting with the primary tagged baits Nanog and another stem-cell marker                                             confirmed in the literature27. Green circles indicate proteins whose knockout
protein Rex1, interaction partners of both Nanog and Rex1 were identified.                                            results in defects in proliferation and/or survival of the inner cell mass or
The validated interactors such as Dax1, Nac1, Zfp281 and Oct4 served as                                               other aspects of early development; blue circles indicate proteins whose
secondary tagged baits for the identification of tertiary interacting partners.                                       reduction by RNA-mediated interference results in defects in self-renewal
Selected high-confidence components of multiprotein complexes are listed                                              and/or differentiation of ES cells; yellow circles are proteins whose knockout
in the table. Proteins shared by multiple tagged baits are shaded similarly.                                          results in later developmental defects; white circles denote proteins for which
Proteins in parentheses are present predominantly in tagged samples with                                              no loss-of-function data are available. c, Co-regulation of proteins in the
some peptide presence in one of the controls during one-step purifications.                                           network on differentiation. Microarray data were curated from the
b, Depiction of the features of the interactome. Proteins with red labels are                                         literature28 and are presented in rank order relative to Rex1.
                                                                                                                                                                                                      367
                                                                                      ©2006 Nature Publishing Group
LETTERS                                                                                                                                    NATURE | Vol 444 | 16 November 2006



along different lineages, which is a requisite for maintaining the                           5.    Silva, J., Chambers, I., Pollard, S. & Smith, A. Nanog promotes transfer of
                                                                                                   pluripotency after cell fusion. Nature 441, 997–1001 (2006).
pluripotent state.
                                                                                             6.    Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of
   Last, the multiple interactions between critical factors also predict                           pluripotency in mouse epiblast and ES cells. Cell 113, 631–642 (2003).
that proteins within the network influence the function of other                             7.    Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency
members, either positively or negatively, and that the stoichiometry                               sustaining factor in embryonic stem cells. Cell 113, 643–655 (2003).
within complexes is important for maintaining pluripotency. This                             8.    Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo
                                                                                                   depends on the POU transcription factor Oct4. Cell 95, 379–391 (1998).
latter conclusion is consistent with dosage-dependent effects for Oct4                       9.    Avilion, A. A. et al. Multipotent cell lineages in early mouse development depend
(ref. 24) and Nanog25. Given the numerous gene targets of the pro-                                 on SOX2 function. Genes Dev. 17, 126–140 (2003).
teins within the network, it is likely that subsets of targets are regu-                     10.   de Boer, E. et al. Efficient biotinylation and single-step purification of tagged
lated by different complexes. We have shown that Gata6 promoter                                    transcription factors in mammalian cells and transgenic mice. Proc. Natl Acad. Sci.
                                                                                                   USA 100, 7480–7485 (2003).
sequences are bound by Nac1, Zfp281 and Nanog. Presumably, pro-
                                                                                             11.   Krogan, N. J. et al. Global landscape of protein complexes in the yeast
teins within the network, such as Dax1 and Sall4, also bind other                                  Saccharomyces cerevisiae. Nature 440, 637–643 (2006).
targets with Nanog, Oct4 and/or Sox2 (among other proteins).                                 12.   Niakan, K. K. et al. Novel role for the orphan nuclear receptor Dax1 in
Accordingly, the combinatorial control of target genes will be far                                 embryogenesis, different from steroidogenesis. Mol. Genet. Metab. 88, 261–271
greater in complexity than suggested by recent chromatin occupancy                                 (2006).
                                                                                             13.   Sakaki-Yumoto, M. et al. The murine homolog of SALL4, a causative gene in
studies19,20.                                                                                      Okihiro syndrome, is essential for embryonic stem cell proliferation, and
   Starting from a central regulator of transcription in ES cells,                                 cooperates with Sall1 in anorectal, heart, brain and kidney development.
namely Nanog, followed by iterative tagging and purification of                                    Development 133, 3005–3013 (2006).
Nanog-associated proteins, we have developed a protein interaction                           14.   Mackler, S. A., Homan, Y. X., Korutla, L., Conti, A. C. & Blendy, J. A. The mouse
                                                                                                   nac1 gene, encoding a cocaine-regulated Bric-a-brac Tramtrac Broad complex/
network. Taken together, the extraordinary enrichment for essential                                Pox virus and Zinc finger protein, is regulated by AP1. Neuroscience 121, 355–361
genes, the coexpression of most genes, and their roles as both targets                             (2003).
and effectors indicate that this mini-interactome might serve as a                           15.   Mackler, S. A. et al. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-
functional module committed to maintaining ES cell pluripotency.                                   induced sensitization in the rat. J. Neurosci. 20, 6210–6217 (2000).
Whereas proteins of the network cooperate to maintain pluripo-                               16.   Law, D. J., Du, M., Law, G. L. & Merchant, J. L. ZBP-99 defines a conserved family
                                                                                                   of transcription factors and regulates ornithine decarboxylase gene expression.
tency, their interdependence renders the cell susceptible to rapid loss                            Biochem. Biophys. Res. Commun. 262, 113–120 (1999).
of pluripotency on the downregulation, or inactivation, of any one of                        17.   Thompson, J. R. & Gudas, L. J. Retinoic acid induces parietal endoderm but not
many components. How differences between mouse and human ES                                        primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma
cells are reflected in the network, and whether components of the                                  stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene. Mol. Cell.
                                                                                                   Endocrinol. 195, 119–133 (2002).
network that are not strictly specific to ES cells are employed by other                     18.   Batagelj, V. & Mrvar, A. Pajek—program for large network analysis. Connections
types of stem cells for controlling self-renewal versus differentiation,                           21, 47–57 (1998).
are topics worthy of future study. Last, the network provides a frame-                       19.   Loh, Y. H. et al. The Oct4 and Nanog transcription network regulates pluripotency
work for exploring the combinations of factors that may permit                                     in mouse embryonic stem cells. Nature Genet. 38, 431–440 (2006).
faithful reprogramming of differentiated cells to an ES cell state26.                        20.   Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic
                                                                                                   stem cells. Cell 122, 947–956 (2005).
                                                                                             21.   Albert, R., Jeong, H. & Barabasi, A. L. Error and attack tolerance of complex
METHODS                                                                                            networks. Nature 406, 378–382 (2000).
In vivo biotinylation, affinity purification and mass spectrometry. J1 ES cells              22.   Lauberth, S. M. & Rauchman, M. A conserved twelve amino acid motif in sall1
were transfected with a plasmid construct expressing BirAV5his followed by selec-                  recruits nuRD. J. Biol. Chem. 281, 23922–23931 (2006).
tion with G418 (300 mg ml21). Clones were picked and expanded for western                    23.   Korutla, L., Wang, P. J. & Mackler, S. A. The POZ/BTB protein NAC1 interacts with
blotting by using anti-V5–HRP (Invitrogen). A BirA-expressing ES clone was then                    two different histone deacetylases in neuronal-like cultures. J. Neurochem. 94,
used for transfection with plasmid constructs containing biotin (or Flag–biotin)-                  786–793 (2005).
tagged cDNAs. ES cells expressing tagged cDNA were identified by western blot-               24.   Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3/4 defines
                                                                                                   differentiation, dedifferentiation or self-renewal of ES cells. Nature Genet. 24,
ting with anti-streptavidin–HRP of the total lysates or nuclear extracts. One-step
                                                                                                   372–376 (2000).
affinity purification with streptavidin-agarose was performed as described10. In             25.   Hatano, S. Y. et al. Pluripotential competence of cells associated with Nanog
brief, nuclear extracts from ES cells expressing BirA and biotin-tagged cDNA were                  activity. Mech. Dev. 122, 67–79 (2005).
incubated with streptavidin-agarose in a buffer containing 1 3 Tris-buffered saline          26.   Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse
(TBS), 350 mM NaCl and 0.3% Nonidet P40. Binding was performed at 4 uC for                         embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676
1 h to overnight on a rocking platform, followed by six washes in binding solution.                (2006).
Bound material was eluted by boiling for 5 min in Laemmli buffer, fractionated on            27.   Lee, J., Rhee, B. K., Bae, G. Y., Han, Y. M. & Kim, J. Stimulation of Oct-4 activity by
a 10% SDS-polyacrylamide gel, and subjected to LC–MS/MS sequencing and data                        Ewing’s sarcoma protein. Stem Cells 23, 738–751 (2005).
analysis (see Supplementary Methods for details).                                            28.   Perez-Iratxeta, C. et al. Study of stem cell function using microarray experiments.
                                                                                                   FEBS Lett. 579, 1795–1801 (2005).
   For tandem purification, nuclear extracts were incubated overnight with anti-
M2 Flag-agarose (Sigma) at 4 uC on a rocking platform. On day 2, after extensive             Supplementary Information is linked to the online version of the paper at
washing with 1 3 TBS, bound materials were eluted by using Flag peptide                      www.nature.com/nature.
(Sigma). The pooled eluate was then used for streptavidin-agarose capture as
                                                                                             Acknowledgements We thank A. Cantor for biotin tagging constructs and for
described above.                                                                             advice on affinity purification and chromatography; Y. Fujiwara and M. Kaku for
   Details of other methods are provided in Supplementary Materials.                         technical assistance and for Oct4–GFP ES cells; T. De Lange for Rif1 antibody;
                                                                                             S. Mackler for Nac1 antibody; S. Lowe and S. Elledge for shRNA vectors; M. Vidal
Received 10 April; accepted 27 September 2006.                                               and A.-L. Barabasi for advice and discussion on networks; and R. Tomaino and
Published online 8 November 2006.                                                            S. Gygi for performing LC–MS/MS and for providing advice and assistance in data
1.    Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured   collection and analysis. S.H.O. is an Investigator of the HHMI.
      in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA         Author Contributions S.R. and J.C. contributed equally to this study. J.W. and
      78, 7634–7638 (1981).                                                                  S.H.O. conceived and initiated the study. J.W., J.C., X.S., D.N.L. and T.W.T.
2.    Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from    performed the experiments. S.R. and J.W. analysed data and bioinformatics of the
      mouse embryos. Nature 292, 154–156 (1981).                                             network. J.W. and S.H.O. wrote the manuscript.
3.    Donovan, P. J. & Gearhart, J. The end of the beginning for pluripotent stem cells.
      Nature 414, 92–97 (2001).                                                              Author Information Reprints and permissions information is available at
4.    Prelle, K., Zink, N. & Wolf, E. Pluripotent stem cells—model of embryonic              www.nature.com/reprints. The authors declare no competing financial interests.
      development, tool for gene targeting, and basis of cell therapy. Anat. Histol.         Correspondence and requests for materials should be addressed to S.H.O.
      Embryol. 31, 169–186 (2002).                                                           (stuart_orkin@dfci.harvard.edu).




368
                                                                        ©2006 Nature Publishing Group
